TLIS — Talis Biomedical Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
- $2.92m
- -$56.95m
- $2.13m
Brief: Talis Biomedical Says Accepting Voluntary Resignation Of Heinrich Dreismann From Board Effective August 1
Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
Talis Biomedical up on plans to explore strategic options, job cuts
Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash
Brief: Talis Biomedical To Report Second Quarter 2023 Financial Results On August 10
Brief: Talis Biomedical Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Talis Biomedical Announces 1-For-15 Reverse Stock Split
Brief: Talis Biomedical Corp - On May 19 Board Expanded Number Of Directors Of Board From Seven Directors To Eight Directors
Brief: Talis Biomedical Announces Business Update And First Quarter 2023 Financial Results
Talis Biomedical Corp expected to post a loss of 73 cents a share - Earnings Preview
Talis Biomedical Corp expected to post a loss of 73 cents a share - Earnings Preview
Brief: Talis Biomedical Says On April 7, J. Roger Moody, Jr. Notified Co That He Will Step Down As Company's CFO, Effective April 21, 2023
U.S. RESEARCH ROUNDUP-Heska, Prudential Financial, ServiceNow
Brief: Talis Announces Fourth Quarter And Full Year 2022 Financial Results
Talis Biomedical Corp expected to post a loss of 68 cents a share - Earnings Preview
Brief: Talis Biomedical On Aug 12 Filed A Request With U.S. FDA To Revoke Emergency Use Authorization For Talis One Covid-19 Test System
Brief: Talis Biomedical Provides Business Update And Reports Second Quarter Financial Results
Brief: Talis Biomedical Files For Resale Of Up To 37.5 Million Shares Of Common Stock
Talis Biomedical Corp expected to post a loss of $1.18 a share - Earnings Preview